{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:14:54Z","timestamp":1747152894237,"version":"3.40.5"},"publisher-location":"Cham","reference-count":138,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030719326"},{"type":"electronic","value":"9783030719333"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/5584_2020_581","type":"book-chapter","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T13:04:00Z","timestamp":1600088640000},"page":"159-186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Outcome of Stem Cell-Based Therapies on the Immune Responses in Rheumatoid Arthritis"],"prefix":"10.1007","author":[{"given":"Peyvand Parhizkar","family":"Roudsari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepideh","family":"Alavi-Moghadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1767-7475","authenticated-orcid":false,"given":"Mostafa","family":"Rezaei-Tavirani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9522-5215","authenticated-orcid":false,"given":"Parisa","family":"Goodarzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8370-9557","authenticated-orcid":false,"given":"Akram","family":"Tayanloo-Beik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Forough Azam","family":"Sayahpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5386-7597","authenticated-orcid":false,"given":"Bagher","family":"Larijani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5001-5006","authenticated-orcid":false,"given":"Babak","family":"Arjmand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,15]]},"reference":[{"issue":"4","key":"581_CR1","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.reumae.2013.03.002","volume":"9","author":"L Abasolo","year":"2013","unstructured":"Abasolo L, Tob\u00edas A, Leon L, Carmona L, Fernandez-Rueda JL, Rodriguez AB, Fernandez-Gutierrez B, Jover JA (2013) Weather conditions may worsen symptoms in rheumatoid arthritis patients: the possible effect of temperature. Reumatolog\u00eda Cl\u00ednica (English Edition) 9(4):226\u2013228","journal-title":"Reumatolog\u00eda Cl\u00ednica (English Edition)"},{"issue":"7","key":"581_CR2","doi-asserted-by":"publisher","first-page":"873","DOI":"10.17219\/acem\/73720","volume":"27","author":"H Abdelmawgoud","year":"2018","unstructured":"Abdelmawgoud H, Saleh A (2018) Anti-inflammatory and antioxidant effects of mesenchymal and hematopoietic stem cells in a rheumatoid arthritis rat model. Adv Clin Exp Med 27(7):873\u2013880","journal-title":"Adv Clin Exp Med"},{"issue":"19","key":"581_CR3","doi-asserted-by":"publisher","first-page":"4750","DOI":"10.3390\/ijms20194750","volume":"20","author":"G Abughanam","year":"2019","unstructured":"Abughanam G, Elkashty OA, Liu Y, Bakkar MO, Tran SD (2019) Mesenchymal stem cells extract (MSCsE)-based therapy alleviates xerostomia and Keratoconjunctivitis sicca in Sjogren\u2019s syndrome-like disease. Int J Mol Sci 20(19):4750","journal-title":"Int J Mol Sci"},{"issue":"5","key":"581_CR4","first-page":"465","volume":"19","author":"HR Aghayan","year":"2014","unstructured":"Aghayan HR, Soleimani M, Goodarzi P, Norouzi-Javidan A, Emami-Razavi SH, Larijani B, Arjmand B (2014) Magnetic resonance imaging of transplanted stem cell fate in stroke. J Res Med Sci 19(5):465\u2013471","journal-title":"J Res Med Sci"},{"key":"581_CR5","volume-title":"Methods in molecular biology","author":"HR Aghayan","year":"2020","unstructured":"Aghayan HR, Payab M, Mohamadi-Jahani F, Aghayan SS, Larijani B, Arjmand B (2020) GMP-compliant production of human placenta-derived mesenchymal stem cells. In: Methods in molecular biology. Springer, New York"},{"issue":"13","key":"581_CR6","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS (2018) Diagnosis and management of rheumatoid arthritis: a review. JAMA 320(13):1360\u20131372","journal-title":"JAMA"},{"issue":"1","key":"581_CR7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/annrheumdis-2015-208918","volume":"76","author":"JM \u00c1lvaro-Gracia","year":"2017","unstructured":"\u00c1lvaro-Gracia JM, Jover JA, Garc\u00eda-Vicu\u00f1a R, Carre\u00f1o L, Alonso A, Marsal S, Blanco F, Mart\u00ednez-Taboada VM, Taylor P, Mart\u00edn-Mart\u00edn C (2017) Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib\/IIa clinical trial. Ann Rheum Dis 76(1):196\u2013202","journal-title":"Ann Rheum Dis"},{"key":"581_CR8","unstructured":"Arbel\u00e1ez-Cort\u00e9s \u00c1, Bejarano-Pineda L, Toro-Guti\u00e9rrez CE (2013) Autologous peripheral hematopoietic stem cell transplantation. Autoimmunity: from Bench to Bedside [Internet]. El Rosario University Press"},{"issue":"3","key":"581_CR9","first-page":"144","volume":"55","author":"B Arjmand","year":"2017","unstructured":"Arjmand B, Goodarzi P, Mohamadi-Jahani F, Falahzadeh K, Larijani B (2017) Personalized regenerative medicine. Acta Med Iran 55(3):144\u2013149","journal-title":"Acta Med Iran"},{"key":"581_CR10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3389\/fendo.2019.00761","volume":"10","author":"B Arjmand","year":"2019","unstructured":"Arjmand B, Goodarzi P, Aghayan HR, Payab M, Rahim F, Alavi-Moghadam S, Mohamadi-Jahani F, Larijani B (2019) Co-transplantation of human fetal mesenchymal and hematopoietic stem cells in type 1 diabetic mice model. Front Endocrinol (Lausanne) 10:761","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"581_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1001\/jama.1974.03230410043024","volume":"229","author":"A Askari","year":"1974","unstructured":"Askari A, Moskowitz RW, Goldberg VM (1974) Subcutaneous rheumatoid nodules and serum rheumatoid factor without arthritis. JAMA 229(3):319\u2013320","journal-title":"JAMA"},{"key":"581_CR12","doi-asserted-by":"crossref","unstructured":"Atoui A, El Labban M, Ghaoui N, El Darsa H, El Cheikh J, Bazarbachi A (2019) Complete remission of seronegative rheumatoid arthritis following haplo-identical stem cell transplantation for peripheral T-cell lymphoma. Bone Marrow Transplant 55:979\u2013981","DOI":"10.1038\/s41409-019-0635-9"},{"key":"581_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.intimp.2017.03.016","volume":"47","author":"R Baharlou","year":"2017","unstructured":"Baharlou R, Ahmadi-Vasmehjani A, Faraji F, Atashzar MR, Khoubyari M, Ahi S, Erfanian S, Navabi S-S (2017) Human adipose tissue-derived mesenchymal stem cells in rheumatoid arthritis: regulatory effects on peripheral blood mononuclear cells activation. Int Immunopharmacol 47:59\u201369","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"581_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrm3721","volume":"15","author":"N Barker","year":"2014","unstructured":"Barker N (2014) Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol 15(1):19\u201333","journal-title":"Nat Rev Mol Cell Biol"},{"key":"581_CR15","doi-asserted-by":"publisher","unstructured":"Bergot A-S, Giri R, Thomas R (2020) The microbiome and rheumatoid arthritis. Best Pract Res Clin Rheumatol:101497. https:\/\/doi.org\/10.1016\/j.berh.2020.101497","DOI":"10.1016\/j.berh.2020.101497"},{"issue":"1","key":"581_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-2014-8","volume":"21","author":"J-M Berthelot","year":"2019","unstructured":"Berthelot J-M, Le Goff B, Maugars Y (2019) Bone marrow mesenchymal stem cells in rheumatoid arthritis, spondyloarthritis, and ankylosing spondylitis: problems rather than solutions? Arthritis Res Ther 21(1):239","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"581_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-016-1170-0","volume":"17","author":"K Bickham","year":"2016","unstructured":"Bickham K, Kivitz AJ, Mehta A, Frontera N, Shah S, Stryszak P, Popmihajlov Z, Peloso PM (2016) Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial. BMC Musculoskelet Disord 17(1):331","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"581_CR18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/JCN.0b013e318197a6a5","volume":"24","author":"JK Biehl","year":"2009","unstructured":"Biehl JK, Russell B (2009) Introduction to stem cell therapy. J Cardiovasc Nurs 24(2):98","journal-title":"J Cardiovasc Nurs"},{"issue":"2","key":"581_CR19","doi-asserted-by":"publisher","first-page":"S336","DOI":"10.1016\/j.jaci.2009.09.032","volume":"125","author":"AC Brignier","year":"2010","unstructured":"Brignier AC, Gewirtz AM (2010) Embryonic and adult stem cell therapy. J Allergy Clin Immunol 125(2):S336\u2013S344","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"581_CR20","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1002\/1529-0131(199911)42:11<2281::AID-ANR4>3.0.CO;2-E","volume":"42","author":"RK Burt","year":"1999","unstructured":"Burt RK, Georganas C, Schroeder J, Traynor A, Stefka J, Schuening F, Graziano F, Mineishi S, Brush M, Fishman M (1999a) Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: sustained response in two of four patients. Arthritis Rheum 42(11):2281\u20132285","journal-title":"Arthritis Rheum"},{"key":"581_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/978-1-4615-4987-1_8","volume-title":"Advances in allogeneic hematopoietic stem cell transplantation","author":"RK Burt","year":"1999","unstructured":"Burt RK, Traynor A, Burns W (1999b) Hematopoietic stem cell transplantation of multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosus. In: Advances in allogeneic hematopoietic stem cell transplantation. Springer, Boston, pp 157\u2013184"},{"key":"581_CR22","first-page":"42","volume":"64","author":"RK Burt","year":"2001","unstructured":"Burt RK, Barr W, Oyama Y, Traynor A, Slavin S (2001) Future strategies in hematopoietic stem cell transplantation for rheumatoid arthritis. J Rheumatol Suppl 64:42\u201348","journal-title":"J Rheumatol Suppl"},{"key":"581_CR23","doi-asserted-by":"crossref","unstructured":"Caglayan S, Ahrens TD, Cie\u015blar-Pobuda A, Staerk J (2019) Chapter 3 Modern ways of obtaining stem cells. In: Stem cells and biomaterials for regenerative medicine. Elsevier, pp 17\u201336","DOI":"10.1016\/B978-0-12-812258-7.00003-4"},{"issue":"26","key":"581_CR24","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1056\/NEJMoa021907","volume":"347","author":"FK Chan","year":"2002","unstructured":"Chan FK, Hung LC, Suen BY, Wu JC, Lee KC, Leung VK, Hui AJ, To KF, Leung WK, Wong VW (2002) Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med 347(26):2104\u20132110","journal-title":"N Engl J Med"},{"key":"581_CR25","doi-asserted-by":"crossref","unstructured":"Chen Y, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor R (2008) Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. NIHR Health Technology Assessment programme: Executive Summaries, NIHR Journals Library","DOI":"10.3310\/hta12110"},{"issue":"12","key":"581_CR26","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.3390\/cells8121497","volume":"8","author":"K Clark","year":"2019","unstructured":"Clark K, Zhang S, Barthe S, Kumar P, Pivetti C, Kreutzberg N, Reed C, Wang Y, Paxton Z, Farmer D (2019) Placental mesenchymal stem cell-derived extracellular vesicles promote myelin regeneration in an animal model of multiple sclerosis. Cell 8(12):1497","journal-title":"Cell"},{"issue":"3","key":"581_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/ar4174","volume":"15","author":"LJ Crofford","year":"2013","unstructured":"Crofford LJ (2013) Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther 15(3):S2","journal-title":"Arthritis Res Ther"},{"key":"581_CR28","volume-title":"Rheumatoid arthritis: early diagnosis and treatment","author":"JJ Cush","year":"2010","unstructured":"Cush JJ, Kavanaugh A, Weinblatt ME (2010) Rheumatoid arthritis: early diagnosis and treatment. Professional Communications, West Islip"},{"issue":"1","key":"581_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0634-1","volume":"17","author":"C De Bari","year":"2015","unstructured":"De Bari C (2015) Are mesenchymal stem cells in rheumatoid arthritis the good or bad guys? Arthritis Res Ther 17(1):113","journal-title":"Arthritis Res Ther"},{"key":"581_CR30","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.3389\/fimmu.2019.01743","volume":"10","author":"PG de Oliveira","year":"2019","unstructured":"de Oliveira PG, Farinon M, Sanchez-Lopez E, Miyamoto S, Guma M (2019) Fibroblast-like Synoviocytes glucose metabolism as a therapeutic target in rheumatoid arthritis. Front Immunol 10:1743","journal-title":"Front Immunol"},{"issue":"25","key":"581_CR31","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1056\/NEJMoa032534","volume":"350","author":"JC Edwards","year":"2004","unstructured":"Edwards JC, Szczepa\u0144ski L, Szechi\u0144ski J, Filipowicz-Sosnowska A, Emery P, Close DR, Stevens RM, Shaw T (2004) Efficacy of B-cell\u2013targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350(25):2572\u20132581","journal-title":"N Engl J Med"},{"issue":"4","key":"581_CR32","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/eos.12533","volume":"126","author":"RMN El Qashty","year":"2018","unstructured":"El Qashty RMN, Mohamed NN, Radwan LRS, Ibrahim FMM (2018) Effect of bone marrow mesenchymal stem cells on healing of temporomandibular joints in rats with induced rheumatoid arthritis. Eur J Oral Sci 126(4):272\u2013281","journal-title":"Eur J Oral Sci"},{"issue":"7","key":"581_CR33","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/qjmed\/hcu033","volume":"107","author":"J El-Jawhari","year":"2014","unstructured":"El-Jawhari J, El-Sherbiny Y, Jones E, McGonagle D (2014) Mesenchymal stem cells, autoimmunity and rheumatoid arthritis. QJM Int J Med 107(7):505\u2013514","journal-title":"QJM Int J Med"},{"key":"581_CR34","doi-asserted-by":"crossref","unstructured":"Farquhar H, Vassallo R, Edwards AL, Matteson EL (2019) Pulmonary complications of rheumatoid arthritis. In: Seminars in respiratory and critical care medicine. Thieme Medical Publishers, New York, NY","DOI":"10.1055\/s-0039-1683995"},{"issue":"10","key":"581_CR35","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.biocel.2010.06.012","volume":"42","author":"DL Faustman","year":"2010","unstructured":"Faustman DL, Davis M (2010) Stem cells in the spleen: therapeutic potential for Sjogren\u2019s syndrome, type I diabetes, and other disorders. Int J Biochem Cell Biol 42(10):1576\u20131579","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"581_CR36","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","volume":"46","author":"GS Firestein","year":"2017","unstructured":"Firestein GS, McInnes IB (2017) Immunopathogenesis of rheumatoid arthritis. Immunity 46(2):183\u2013196","journal-title":"Immunity"},{"issue":"10","key":"581_CR37","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.amjmed.2008.06.011","volume":"121","author":"SE Gabriel","year":"2008","unstructured":"Gabriel SE (2008) Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med 121(10):S9\u2013S14","journal-title":"Am J Med"},{"issue":"3","key":"581_CR38","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10072-018-3670-1","volume":"40","author":"F Ge","year":"2019","unstructured":"Ge F, Lin H, Li Z, Chang T (2019) Efficacy and safety of autologous hematopoietic stem-cell transplantation in multiple sclerosis: a systematic review and meta-analysis. Neurol Sci 40(3):479\u2013487","journal-title":"Neurol Sci"},{"issue":"9","key":"581_CR39","first-page":"651","volume":"52","author":"P Goodarzi","year":"2014","unstructured":"Goodarzi P, Aghayan HR, Soleimani M, Norouzi-Javidan A, Mohamadi-Jahani F, Jahangiri S, Emami-Razavi SH, Larijani B, Arjmand B (2014) Stem cell therapy for treatment of epilepsy. Acta Med Iran 52(9):651\u2013655","journal-title":"Acta Med Iran"},{"key":"581_CR40","first-page":"168","volume":"29","author":"P Goodarzi","year":"2015","unstructured":"Goodarzi P, Aghayan HR, Larijani B, Soleimani M, Dehpour AR, Sahebjam M, Ghaderi F, Arjmand B (2015) Stem cell-based approach for the treatment of Parkinson\u2019s disease. Med J Islam Repub Iran 29:168","journal-title":"Med J Islam Repub Iran"},{"key":"581_CR41","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/5584_2018_251","volume":"1119","author":"P Goodarzi","year":"2018","unstructured":"Goodarzi P, Larijani B, Alavi-Moghadam S, Tayanloo-Beik A, Mohamadi-Jahani F, Ranjbaran N, Payab M, Falahzadeh K, Mousavi M, Arjmand B (2018) Mesenchymal stem cells-derived exosomes for wound regeneration. Adv Exp Med Biol 1119:119\u2013131","journal-title":"Adv Exp Med Biol"},{"issue":"Suppl1","key":"581_CR42","first-page":"30","volume":"8","author":"P Goodarzi","year":"2019","unstructured":"Goodarzi P, Alavi-Moghadam S, Payab M, Larijani B, Rahim F, Gilany K, Bana N, Tayanloo-Beik A, Foroughi Heravani N, Hadavandkhani M, Arjmand B (2019a) Metabolomics analysis of mesenchymal stem cells. Int J Mol Cell Med 8(Suppl1):30\u201340","journal-title":"Int J Mol Cell Med"},{"issue":"1","key":"581_CR43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10561-018-9741-y","volume":"20","author":"P Goodarzi","year":"2019","unstructured":"Goodarzi P, Falahzadeh K, Aghayan H, Payab M, Larijani B, Alavi-Moghadam S, Tayanloo-Beik A, Adibi H, Gilany K, Arjmand B (2019b) Therapeutic abortion and ectopic pregnancy: alternative sources for fetal stem cell research and therapy in Iran as an Islamic country. Cell Tissue Bank 20(1):11\u201324","journal-title":"Cell Tissue Bank"},{"issue":"2","key":"581_CR44","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10561-019-09773-8","volume":"20","author":"P Goodarzi","year":"2019","unstructured":"Goodarzi P, Payab M, Alavi-Moghadam S, Larijani B, Rahim F, Bana N, Sarvari M, Adibi H, Foroughi Heravani N, Hadavandkhani M, Arjmand B (2019c) Development and validation of Alzheimer\u2019s disease animal model for the purpose of regenerative medicine. Cell Tissue Bank 20(2):141\u2013151","journal-title":"Cell Tissue Bank"},{"key":"581_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2018.07.009","volume":"160","author":"N Gurusamy","year":"2018","unstructured":"Gurusamy N, Alsayari A, Rajasingh S, Rajasingh J (2018) Adult stem cells for regenerative therapy. Prog Mol Biol Transl Sci (Elsevier) 160:1\u201322","journal-title":"Prog Mol Biol Transl Sci (Elsevier)"},{"issue":"12","key":"581_CR46","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1093\/rheumatology\/ker289","volume":"50","author":"AV Hadjinicolaou","year":"2011","unstructured":"Hadjinicolaou AV, Nisar MK, Bhagat S, Parfrey H, Chilvers ER, \u00d6st\u00f6r AJ (2011) Non-infectious pulmonary complications of newer biological agents for rheumatic diseases\u2014a systematic literature review. Rheumatology 50(12):2297\u20132305","journal-title":"Rheumatology"},{"issue":"4","key":"581_CR47","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3899\/jrheum.141368","volume":"43","author":"HE Harris","year":"2016","unstructured":"Harris HE, Tweedie F, White M, Samson K (2016) How to motivate patients with rheumatoid arthritis to quit smoking. J Rheumatol 43(4):691\u2013698","journal-title":"J Rheumatol"},{"key":"581_CR48","first-page":"105","volume":"3","author":"E Hatzimichael","year":"2010","unstructured":"Hatzimichael E, Tuthill M (2010) Hematopoietic stem cell transplantation. Stem Cells Cloning Adv Appl 3:105","journal-title":"Stem Cells Cloning Adv Appl"},{"issue":"Suppl 3","key":"581_CR49","doi-asserted-by":"publisher","first-page":"A557","DOI":"10.1136\/annrheumdis-2013-eular.1666","volume":"72","author":"K Henriksson","year":"2013","unstructured":"Henriksson K, J\u00f6rgensen L, From J, Stratelis G (2013) FRI0539\u00a0Patient reported adherence to co-prescribed ppi gastro protection treatment in osteoarthritis, rheumatoid arthritis or ankylosing spondylitis patients using nsaid. Ann Rheum Dis 72(Suppl 3):A557\u2013A557","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"581_CR50","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s002960050120","volume":"19","author":"S Hirohata","year":"2000","unstructured":"Hirohata S, Yanagida T, Nakamura H, Yoshino S, Tomita T, Ochi T (2000) Bone marrow CD34+ progenitor cells from rheumatoid arthritis patients support spontaneous transformation of peripheral blood B cells from healthy individuals. Rheumatol Int 19(4):153\u2013159","journal-title":"Rheumatol Int"},{"issue":"3","key":"581_CR51","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1189\/jlb.70.3.413","volume":"70","author":"S Hirohata","year":"2001","unstructured":"Hirohata S, Yanagida T, Nagai T, Sawada T, Nakamura H, Yoshino S i, Tomita T, Ochi T (2001) Induction of fibroblast-like cells from CD34+ progenitor cells of the bone marrow in rheumatoid arthritis. J Leukoc Biol 70(3):413\u2013421","journal-title":"J Leukoc Biol"},{"issue":"4","key":"581_CR52","doi-asserted-by":"publisher","first-page":"537","DOI":"10.5665\/sleep.1742","volume":"35","author":"MR Irwin","year":"2012","unstructured":"Irwin MR, Olmstead R, Carrillo C, Sadeghi N, FitzGerald JD, Ranganath VK, Nicassio PM (2012) Sleep loss exacerbates fatigue, depression, and pain in rheumatoid arthritis. Sleep 35(4):537\u2013543","journal-title":"Sleep"},{"issue":"2","key":"581_CR53","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1006\/excr.1999.4678","volume":"253","author":"CB Johansson","year":"1999","unstructured":"Johansson CB, Svensson M, Wallstedt L, Janson AM, Fris\u00e9n J (1999) Neural stem cells in the adult human brain. Exp Cell Res 253(2):733\u2013736","journal-title":"Exp Cell Res"},{"issue":"4","key":"581_CR54","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1136\/ard.60.4.305","volume":"60","author":"C Jorgensen","year":"2001","unstructured":"Jorgensen C, Noel D, Apparailly F, Sany J (2001) Stem cells for repair of cartilage and bone: the next challenge in osteoarthritis and rheumatoid arthritis. Ann Rheum Dis 60(4):305\u2013309","journal-title":"Ann Rheum Dis"},{"key":"581_CR55","first-page":"185","volume-title":"Advances in induced pluripotent stem cell","author":"R Joseph","year":"2020","unstructured":"Joseph R, Wang Y, Zhong L, Palecek SP, Nagy K, Agha-Mohammadi S (2020) Advances in induced pluripotent stem cell. In: Advances in induced pluripotent stem cell, p 185"},{"issue":"3","key":"581_CR56","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4078\/jrd.2018.25.3.158","volume":"25","author":"SY Jung","year":"2018","unstructured":"Jung SY (2018) Adult stem cell treatment for rheumatoid arthritis. J Rheum Dis 25(3):158\u2013168","journal-title":"J Rheum Dis"},{"issue":"Suppl 2","key":"581_CR57","first-page":"566","volume":"76","author":"S Kafaja","year":"2017","unstructured":"Kafaja S, Segal K, Skerrett D, Itescu S, Furst D (2017) FRI0220\u00a0Allogeneic mesenchymal precursor cells (MPCS): a novel approach to treating biologic refractory rheumatoid arthritis. Ann Rheum Dis 76(Suppl 2):566\u2013567","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"581_CR58","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1136\/ard.2009.120899","volume":"70","author":"H K\u00e4llberg","year":"2011","unstructured":"K\u00e4llberg H, Ding B, Padyukov L, Bengtsson C, R\u00f6nnelid J, Klareskog L, Alfredsson L, E. S. Group (2011) Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis 70(3):508\u2013511","journal-title":"Ann Rheum Dis"},{"key":"581_CR59","doi-asserted-by":"crossref","unstructured":"Karamini A, Bakopoulou A, Andreadis D, Gkiouras K, Kritis A (2020) Therapeutic potential of mesenchymal stromal stem cells in rheumatoid arthritis: a systematic review of in vivo studies. Stem Cell Rev 16:276\u2013287","DOI":"10.1007\/s12015-020-09954-z"},{"issue":"1","key":"581_CR60","doi-asserted-by":"publisher","first-page":"38","DOI":"10.15562\/bmj.v6i1.378","volume":"6","author":"BH Kartiko","year":"2017","unstructured":"Kartiko BH, Siswanto FM, Purwata TE (2017) Mesenchymal stem cell (MSC) as a potential cell therapy for immune related disease. Bali Med J 6(1):38\u201343","journal-title":"Bali Med J"},{"key":"581_CR61","unstructured":"Khaddour K, Mewawalla P (2019) Hematopoietic stem cell transplantation. StatPearls [internet]. StatPearls Publishing"},{"issue":"1","key":"581_CR62","first-page":"111","volume":"89","author":"S Kiatpongsan","year":"2006","unstructured":"Kiatpongsan S, Tannirandorn Y, Virutamasen P (2006) Introduction to stem cell medicine. J Med Assoc Thail 89(1):111","journal-title":"J Med Assoc Thail"},{"issue":"4","key":"581_CR63","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/art.22439","volume":"56","author":"KW Kim","year":"2007","unstructured":"Kim KW, Cho ML, Kim HR, Ju JH, Park MK, Oh HJ, Kim JS, Park SH, Lee SH, Kim HY (2007) Up-regulation of stromal cell\u2013derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L\u2013CD40 interaction. Arthritis Rheum 56(4):1076\u20131086","journal-title":"Arthritis Rheum"},{"issue":"1\u20132","key":"581_CR64","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cellimm.2014.10.005","volume":"292","author":"J-H Kim","year":"2014","unstructured":"Kim J-H, Lee YT, Oh K, Cho J, Lee D-S, Hwang Y-i (2014) Paradoxical effects of human adipose tissue-derived mesenchymal stem cells on progression of experimental arthritis in SKG mice. Cell Immunol 292(1\u20132):94\u2013101","journal-title":"Cell Immunol"},{"key":"581_CR65","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.3389\/fimmu.2018.02226","volume":"9","author":"TW Kragstrup","year":"2018","unstructured":"Kragstrup TW, Andersen T, Heftdal LD, Hvid M, Gerwien J, Sivakumar P, Taylor PC, Senolt L, Deleuran B (2018) The IL-20 cytokine family in rheumatoid arthritis and spondyloarthritis. Front Immunol 9:2226","journal-title":"Front Immunol"},{"issue":"2","key":"581_CR66","first-page":"216","volume":"33","author":"C Lampropoulos","year":"2015","unstructured":"Lampropoulos C, Orfanos P, Bournia V, Karatsourakis T, Mavragani C, Pikazis D, Manoussakis M, Tzioufas A, Moutsopoulos H, Vlachoyiannopoulos P (2015) Adverse events and infections in patients with rheumatoid arthritis treated with conventional drugs or biologic agents: a real world study. Clin Exp Rheumatol 33(2):216\u2013224","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"581_CR67","first-page":"79","volume":"50","author":"B Larijani","year":"2012","unstructured":"Larijani B, NASLI EE, Amini P, Nikbin B, Alimoghaddam K, Amiri S, Malekzadeh R, Mojahed YN, Ghodsi M, Dowlati Y (2012) Stem cell therapy in treatment of different diseases. Acta Med Iran 50(2):79\u201396","journal-title":"Acta Med Iran"},{"issue":"Suppl1","key":"581_CR68","first-page":"41","volume":"8","author":"B Larijani","year":"2019","unstructured":"Larijani B, Goodarzi P, Payab M, Alavi-Moghadam S, Rahim F, Bana N, Abedi M, Arabi M, Adibi H, Gilany K, Arjmand B (2019a) Metabolomics and cell therapy in diabetes mellitus. Int J Mol Cell Med 8(Suppl1):41\u201348","journal-title":"Int J Mol Cell Med"},{"key":"581_CR69","doi-asserted-by":"crossref","unstructured":"Larijani B, Goodarzi P, Payab M, Tayanloo-Beik A, Sarvari M, Gholami M, Gilany K, Nasli-Esfahani E, Yarahmadi M, Ghaderi F, Arjmand B (2019b) The design and application of an appropriate Parkinson\u2019s disease animal model in regenerative medicine. Adv Exp Med Biol 50:79\u201396","DOI":"10.1007\/5584_2019_422"},{"key":"581_CR70","doi-asserted-by":"crossref","unstructured":"Larijani B, Foroughi Heravani N, Alavi-Moghadam S, Goodarzi P, Rezaei-Tavirani M, Payab M, Gholami M, Razi F, Arjmand B (2020) Cell therapy targets for autism Spectrum disorders: hopes, challenges and future directions. Adv Exp Med Biol","DOI":"10.1007\/5584_2020_491"},{"issue":"22","key":"581_CR71","first-page":"1717","volume":"38","author":"PE Lazzerini","year":"2017","unstructured":"Lazzerini PE, Capecchi PL, Laghi-Pasini F (2017) Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis. Eur Heart J 38(22):1717\u20131727","journal-title":"Eur Heart J"},{"issue":"Suppl 2","key":"581_CR72","first-page":"944","volume":"77","author":"YH Lee","year":"2018","unstructured":"Lee YH, Seo YH (2018) SAT0167\u00a0Comparison of the efficacy and tolerability of tocilizumab, sarilumab, and sirukumab in patients with active rheumatoid arthritis: a bayesian network meta-analysis of randomized controlled trials. Ann Rheum Dis 77(Suppl 2):944\u2013944","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"581_CR73","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/j.1365-2133.2007.07682.x","volume":"156","author":"H-H Lee","year":"2007","unstructured":"Lee H-H, Song I-H, Friedrich M, Gauliard A, Detert J, R\u00f6wert J, Audring H, Kary S, Burmester G-R, Sterry W, Worm M (2007) Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-\u03b1 antagonists. Br J Dermatol 156(3):486\u2013491","journal-title":"Br J Dermatol"},{"key":"581_CR74","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-3-319-42252-7_9","volume-title":"Next-generation therapies and technologies for immune-mediated inflammatory diseases","author":"PSC Leung","year":"2017","unstructured":"Leung PSC, Shuai Z, Liu B, Shu SA, Sun L (2017) Stem cell therapy in the treatment of rheumatic diseases and application in the treatment of systemic lupus erythematosus. In: Mina-Osorio P (ed) Next-generation therapies and technologies for immune-mediated inflammatory diseases. Springer International Publishing, Cham, pp 167\u2013198"},{"issue":"22","key":"581_CR75","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","volume":"343","author":"PE Lipsky","year":"2000","unstructured":"Lipsky PE, van der Heijde DM, Clair EWS, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 343(22):1594\u20131602","journal-title":"N Engl J Med"},{"issue":"2","key":"581_CR76","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.pop.2018.02.010","volume":"45","author":"EA Littlejohn","year":"2018","unstructured":"Littlejohn EA, Monrad SU (2018) Early diagnosis and treatment of rheumatoid arthritis. Prim Care 45(2):237\u2013255","journal-title":"Prim Care"},{"issue":"6","key":"581_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/ar3187","volume":"12","author":"Y Liu","year":"2010","unstructured":"Liu Y, Mu R, Wang S, Long L, Liu X, Li R, Sun J, Guo J, Zhang X, Guo J, Yu P, Li C, Liu X, Huang Z, Wang D, Li H, Gu Z, Liu B, Li Z (2010) Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res Ther 12(6):R210","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"581_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/srep12777","volume":"5","author":"R Liu","year":"2015","unstructured":"Liu R, Li X, Zhang Z, Zhou M, Sun Y, Su D, Feng X, Gao X, Shi S, Chen W, Sun L (2015) Allogeneic mesenchymal stem cells inhibited T follicular helper cell generation in rheumatoid arthritis. Sci Rep 5(1):12777","journal-title":"Sci Rep"},{"key":"581_CR79","doi-asserted-by":"publisher","first-page":"8459281","DOI":"10.3389\/fimmu.2019.00798","volume":"10","author":"N Luque-Campos","year":"2019","unstructured":"Luque-Campos N, Contreras-L\u00f3pez RA, Paredes-Mart\u00ednez MJ, Torres MJ, Bahraoui S, Wei M, Espinoza F, Djouad F, Elizondo-Vega RJ, Luz-Crawford P (2019) Mesenchymal stem cells improve rheumatoid arthritis progression by controlling memory T cell response. Front Immunol 10:8459281","journal-title":"Front Immunol"},{"issue":"2","key":"581_CR80","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3892\/br.2012.42","volume":"1","author":"X Ma","year":"2013","unstructured":"Ma X, Xu S (2013) TNF inhibitor therapy for rheumatoid arthritis. Biomed Rep 1(2):177\u2013184","journal-title":"Biomed Rep"},{"key":"581_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105687","volume":"74","author":"D Ma","year":"2019","unstructured":"Ma D, Xu K, Zhang G, Liu Y, Gao J, Tian M, Wei C, Li J, Zhang L (2019) Immunomodulatory effect of human umbilical cord mesenchymal stem cells on T lymphocytes in rheumatoid arthritis. Int Immunopharmacol 74:105687","journal-title":"Int Immunopharmacol"},{"key":"581_CR82","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cpr.2015.03.004","volume":"39","author":"F Matcham","year":"2015","unstructured":"Matcham F, Ali S, Hotopf M, Chalder T (2015) Psychological correlates of fatigue in rheumatoid arthritis: a systematic review. Clin Psychol Rev 39:16\u201329","journal-title":"Clin Psychol Rev"},{"issue":"12","key":"581_CR83","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s00296-014-3040-0","volume":"34","author":"K Mattila","year":"2014","unstructured":"Mattila K, Buttgereit F, Tuominen R (2014) Impact of morning stiffness on working behaviour and performance in people with rheumatoid arthritis. Rheumatol Int 34(12):1751\u20131758","journal-title":"Rheumatol Int"},{"issue":"23","key":"581_CR84","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365(23):2205\u20132219","journal-title":"N Engl J Med"},{"issue":"1","key":"581_CR85","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nrrheum.2015.171","volume":"12","author":"IB McInnes","year":"2016","unstructured":"McInnes IB, Buckley CD, Isaacs JD (2016) Cytokines in rheumatoid arthritis\u2014shaping the immunological landscape. Nat Rev Rheumatol 12(1):63","journal-title":"Nat Rev Rheumatol"},{"key":"581_CR86","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3389\/fimmu.2015.00384","volume":"6","author":"M Mellado","year":"2015","unstructured":"Mellado M, Mart\u00ednez-Mu\u00f1oz L, Cascio G, Lucas P, Pablos JL, Rodr\u00edguez-Frade JM (2015) T cell migration in rheumatoid arthritis. Front Immunol 6:384","journal-title":"Front Immunol"},{"issue":"19","key":"581_CR87","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1242\/dev.02568","volume":"133","author":"HK Mikkola","year":"2006","unstructured":"Mikkola HK, Orkin SH (2006) The journey of developing hematopoietic stem cells. Development 133(19):3733\u20133744","journal-title":"Development"},{"key":"581_CR88","first-page":"8","volume":"64","author":"J Moore","year":"2001","unstructured":"Moore J, Milliken S, David JB, Brooks P (2001) Peripheral blood stem cell transplantation for rheumatoid arthritis\u2013Australian experience. J Rheumatol 64:8\u201312","journal-title":"J Rheumatol"},{"issue":"1","key":"581_CR89","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1038\/sj.bmt.1703944","volume":"32","author":"J Moore","year":"2003","unstructured":"Moore J, Snowden J, Pavletic S, Barr W, Burt R (2003) Hematopoietic stem cell transplantation for severe rheumatoid arthritis. Bone Marrow Transplant 32(1):S53\u2013S56","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"581_CR90","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.clim.2004.12.009","volume":"115","author":"A Mor","year":"2005","unstructured":"Mor A, Abramson SB, Pillinger MH (2005) The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clin Immunol 115(2):118\u2013128","journal-title":"Clin Immunol"},{"issue":"2","key":"581_CR91","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/dvdy.20360","volume":"233","author":"W Murrell","year":"2005","unstructured":"Murrell W, F\u00e9ron F, Wetzig A, Cameron N, Splatt K, Bellette B, Bianco J, Perry C, Lee G, Mackay-Sim A (2005) Multipotent stem cells from adult olfactory mucosa. Dev Dyn 233(2):496\u2013515","journal-title":"Dev Dyn"},{"issue":"4","key":"581_CR92","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/ncprheum0756","volume":"4","author":"NP Nikolov","year":"2008","unstructured":"Nikolov NP, Pavletic SZ (2008) Technology insight: hematopoietic stem cell transplantation for systemic rheumatic disease. Nat Clin Pract Rheumatol 4(4):184\u2013191","journal-title":"Nat Clin Pract Rheumatol"},{"key":"581_CR93","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","volume":"375","author":"SE Nissen","year":"2016","unstructured":"Nissen SE, Yeomans ND, Solomon DH, L\u00fcscher TF, Libby P, Husni ME, Graham DY, Borer JS, Wisniewski LM, Wolski KE (2016) Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med 375:2519\u20132529","journal-title":"N Engl J Med"},{"issue":"4","key":"581_CR94","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00281-017-0619-z","volume":"39","author":"M Noack","year":"2017","unstructured":"Noack M, Miossec P (2017) Selected cytokine pathways in rheumatoid arthritis. Semin Immunopathol 39(4):365\u2013383","journal-title":"Semin Immunopathol"},{"issue":"1","key":"581_CR95","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1600-065X.2008.00648.x","volume":"223","author":"EH Noss","year":"2008","unstructured":"Noss EH, Brenner MB (2008) The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol Rev 223(1):252\u2013270","journal-title":"Immunol Rev"},{"key":"581_CR96","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/B978-0-12-802257-3.00007-9","volume-title":"Molecular and cellular therapies for motor neuron diseases","author":"D O\u2019Connor","year":"2017","unstructured":"O\u2019Connor D (2017) Introduction to gene and stem-cell therapy. In: Molecular and cellular therapies for motor neuron diseases. Elsevier, San Diego, pp 141\u2013165"},{"key":"581_CR97","first-page":"72","volume":"44","author":"JR O\u2019Dell","year":"1996","unstructured":"O\u2019Dell JR, Haire C, Erikson N, Drymalski W, Palmer W, Maloley P, Klassen LW, Wees S, Moore GF (1996) Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate. J Rheumatol Suppl 44:72\u201374","journal-title":"J Rheumatol Suppl"},{"issue":"4","key":"581_CR98","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1056\/NEJMoa1303006","volume":"369","author":"JR O\u2019Dell","year":"2013","unstructured":"O\u2019Dell JR, Mikuls TR, Taylor TH, Ahluwalia V, Brophy M, Warren SR, Lew RA, Cannella AC, Kunkel G, Phibbs CS (2013) Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med 369(4):307\u2013318","journal-title":"N Engl J Med"},{"issue":"9","key":"581_CR99","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/sctm.18-0031","volume":"7","author":"EH Park","year":"2018","unstructured":"Park EH, Lim H s, Lee S, Roh K, Seo KW, Kang KS, Shin K (2018) Intravenous infusion of umbilical cord blood-derived mesenchymal stem cells in rheumatoid arthritis: a phase Ia clinical trial. Stem Cells Transl Med 7(9):636\u2013642","journal-title":"Stem Cells Transl Med"},{"key":"581_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/5584_2018_227","volume":"1089","author":"M Payab","year":"2018","unstructured":"Payab M, Goodarzi P, Foroughi Heravani N, Hadavandkhani M, Zarei Z, Falahzadeh K, Larijani B, Rahim F, Arjmand B (2018) Stem cell and obesity: current state and future perspective. Adv Exp Med Biol 1089:1\u201322","journal-title":"Adv Exp Med Biol"},{"issue":"Suppl 1","key":"581_CR101","doi-asserted-by":"publisher","first-page":"A4","DOI":"10.1136\/annrheumdis-2015-207259.10","volume":"74","author":"M Pedrosa","year":"2015","unstructured":"Pedrosa M, Duarte C, Laranjeira P, Gomes J, Ribeiro T, Santos F, Antunes B, Pedreiro S, Henriques A, Martinho A, Fardilha M, Trindade H, da Silva J, Paiva A (2015) A1.10\u00a0Human bone marrow-derived mesenchymal stromal cells strongly inhibit cytokine production by naive, memory and effector CD4+ and CD8+ T cells from rheumatoid arthritis patients, independently of disease activity status. Ann Rheum Dis 74(Suppl 1):A4\u2013A5","journal-title":"Ann Rheum Dis"},{"issue":"suppl 1","key":"581_CR102","first-page":"S9","volume":"71","author":"T Pincus","year":"2013","unstructured":"Pincus T, Castrej\u00f3n I (2013) Update on methotrexate as the anchor drug for rheumatoid arthritis. Bull NYU Hosp Jt Dis 71(suppl 1):S9","journal-title":"Bull NYU Hosp Jt Dis"},{"issue":"1","key":"581_CR103","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-9-181","volume":"9","author":"JC Ra","year":"2011","unstructured":"Ra JC, Kang SK, Shin IS, Park HG, Joo SA, Kim JG, Kang B-C, Lee YS, Nakama K, Piao M, Sohl B, Kurtz A (2011) Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells. J Transl Med 9(1):181","journal-title":"J Transl Med"},{"key":"581_CR104","first-page":"40","volume":"5","author":"F Rahim","year":"2018","unstructured":"Rahim F, Arjmand B, Shirbandi K, Payab M, Larijani B (2018) Stem cell therapy for patients with diabetes: a systematic review and meta-analysis of metabolomics-based risks and benefits. Stem Cell Investig 5:40","journal-title":"Stem Cell Investig"},{"key":"581_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102400","volume":"110","author":"HU Scherer","year":"2020","unstructured":"Scherer HU, H\u00e4upl T, Burmester GR (2020) The etiology of rheumatoid arthritis. J Autoimmun 110:102400","journal-title":"J Autoimmun"},{"issue":"8","key":"581_CR106","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1136\/annrheumdis-2016-209201","volume":"75","author":"G Schett","year":"2016","unstructured":"Schett G, Emery P, Tanaka Y, Burmester G, Pisetsky DS, Naredo E, Fautrel B, van Vollenhoven R (2016) Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions. Ann Rheum Dis 75(8):1428\u20131437","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"581_CR107","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1182\/bloodadvances.2017014449","volume":"2","author":"JMF Silva","year":"2018","unstructured":"Silva JMF, Ladomenou F, Carpenter B, Chandra S, Sedlacek P, Formankova R, Grandage V, Friswell M, Cant AJ, Nademi Z (2018) Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis. Blood Adv 2(7):777\u2013786","journal-title":"Blood Adv"},{"issue":"6","key":"581_CR108","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/bmt.2011.185","volume":"47","author":"JA Snowden","year":"2012","unstructured":"Snowden JA, Saccardi R, Allez M, Ardizzone S, Arnold R, Cervera R, Denton C, Hawkey C, Labopin M, Mancardi G, Martin R, Moore JJ, Passweg J, Peters C, Rabusin M, Rovira M, van Laar JM, Farge D, E. A. D. W. P. on behalf of the and P. Paediatric Diseases Working (2012) Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 47(6):770\u2013790","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"581_CR109","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/stem.68","volume":"27","author":"L Sun","year":"2009","unstructured":"Sun L, Akiyama K, Zhang H, Yamaza T, Hou Y, Zhao S, Xu T, Le A, Shi S (2009) Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 27(6):1421\u20131432","journal-title":"Stem Cells"},{"issue":"2","key":"581_CR110","first-page":"288","volume":"35","author":"Y Sun","year":"2017","unstructured":"Sun Y, Kong W, Huang S, Shi B, Zhang H, Chen W, Zhang H, Zhao C, Tang X, Yao G (2017) Comparable therapeutic potential of umbilical cord mesenchymal stem cells in collagen-induced arthritis to TNF inhibitor or anti-CD20 treatment. Clin Exp Rheumatol 35(2):288\u2013295","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"581_CR111","doi-asserted-by":"publisher","first-page":"15","DOI":"10.12968\/bjha.2011.5.1.15","volume":"5","author":"J Swann","year":"2011","unstructured":"Swann J (2011) Understanding rheumatoid arthritis: causes and treatment. Brit J Healthc Assist 5(1):15\u201317","journal-title":"Brit J Healthc Assist"},{"issue":"7042","key":"581_CR112","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/nature03728","volume":"435","author":"M Sykes","year":"2005","unstructured":"Sykes M, Nikolic B (2005) Treatment of severe autoimmune disease by stem-cell transplantation. Nature 435(7042):620\u2013627","journal-title":"Nature"},{"issue":"4","key":"581_CR113","first-page":"239","volume":"2","author":"JG Tebib","year":"1991","unstructured":"Tebib JG, Boughaba H, Letroublon MC, Bienvenu J, Noel E, Armanet P, Colson F, Roullet A, Bouvier M (1991) Serum IL-2 level in rheumatoid arthritis: correlation with joint destruction and disease progression. Eur Cytokine Netw 2(4):239\u2013243","journal-title":"Eur Cytokine Netw"},{"issue":"12","key":"581_CR114","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/acr.23225","volume":"69","author":"SK Tedeschi","year":"2017","unstructured":"Tedeschi SK, Frits M, Cui J, Zhang ZZ, Mahmoud T, Iannaccone C, Lin TC, Yoshida K, Weinblatt ME, Shadick NA (2017) Diet and rheumatoid arthritis symptoms: survey results from a rheumatoid arthritis registry. Arthritis Care Res 69(12):1920\u20131925","journal-title":"Arthritis Care Res"},{"issue":"8","key":"581_CR115","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1002\/art.21219","volume":"52","author":"Y Teng","year":"2005","unstructured":"Teng Y, Verburg R, Sont J, Van den Hout W, Breedveld F, Van Laar J (2005) Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation. Arthritis Rheum 52(8):2272\u20132276","journal-title":"Arthritis Rheum"},{"key":"581_CR116","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/978-3-030-23421-8_4","volume-title":"Stem cell transplantation for autoimmune diseases and inflammation","author":"K To","year":"2019","unstructured":"To K, Khan W (2019) Mesenchymal stem cell transplantation in rheumatoid arthritis. In: Stem cell transplantation for autoimmune diseases and inflammation. Springer, Cham, pp 63\u201374"},{"issue":"8","key":"581_CR117","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0198-8859(02)00414-7","volume":"63","author":"RE Toes","year":"2002","unstructured":"Toes RE, Fibbe WE, Breedveld FC, van Laar JM (2002) High dose chemotherapy and autologous hematopoietic stem cell transplantation for rheumatoid arthritis: a review. Hum Immunol 63(8):627\u2013637","journal-title":"Hum Immunol"},{"issue":"1","key":"581_CR118","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/ar614","volume":"5","author":"RS Tuan","year":"2002","unstructured":"Tuan RS, Boland G, Tuli R (2002) Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther 5(1):32","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"581_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60041-2","volume":"10","author":"H Ueyama","year":"2020","unstructured":"Ueyama H, Okano T, Orita K, Mamoto K, Sobajima S, Iwaguro H, Nakamura H (2020) Local transplantation of adipose-derived stem cells has a significant therapeutic effect in a mouse model of rheumatoid arthritis. Sci Rep 10(1):3076","journal-title":"Sci Rep"},{"issue":"10","key":"581_CR120","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1093\/rheumatology\/kel158","volume":"45","author":"J Van Laar","year":"2006","unstructured":"Van Laar J, Tyndall A (2006) Adult stem cells in the treatment of autoimmune diseases. Rheumatology 45(10):1187\u20131193","journal-title":"Rheumatology"},{"issue":"4","key":"581_CR121","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/1529-0131(200104)44:4<754::AID-ANR131>3.0.CO;2-N","volume":"44","author":"RJ Verburg","year":"2001","unstructured":"Verburg RJ, Kruize AA, van den Hoogen FH, Fibbe WE, Petersen EJ, Preijers F, Sont JK, Barge RM, Bijlsma JW, van de Putte LB (2001) High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy. Arthritis Rheum 44(4):754\u2013760","journal-title":"Arthritis Rheum"},{"key":"581_CR122","doi-asserted-by":"crossref","unstructured":"Vishwakarma A, Sharpe P, Shi S, Ramalingam M (2015) Chapter 1 An introduction to stem cell biology and tissue engineering. In: Stem cell biology and tissue engineering in dental sciences. Elsevier, pp 1\u201313","DOI":"10.1016\/B978-0-12-397157-9.00001-1"},{"issue":"6","key":"581_CR123","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s11916-012-0303-x","volume":"16","author":"DA Walsh","year":"2012","unstructured":"Walsh DA, McWilliams DF (2012) Pain in rheumatoid arthritis. Curr Pain Headache Rep 16(6):509\u2013517","journal-title":"Curr Pain Headache Rep"},{"key":"581_CR124","unstructured":"Wang Q, Li X-F, Ma L-H, Li J-X, Chen J-W, Li F, Xue L-J, Bai J (2011) Allogenic derived mesenchymal stem cells transplantation for 4 patients with rheumatoid arthritis [J]. Chin J Allergy Clin Immunol 3"},{"issue":"24","key":"581_CR125","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1089\/scd.2013.0023","volume":"22","author":"L Wang","year":"2013","unstructured":"Wang L, Wang L, Cong X, Liu G, Zhou J, Bai B, Li Y, Bai W, Li M, Ji H (2013) Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. Stem Cells Dev 22(24):3192\u20133202","journal-title":"Stem Cells Dev"},{"key":"581_CR126","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ejmech.2018.09.027","volume":"158","author":"W Wang","year":"2018","unstructured":"Wang W, Zhou H, Liu L (2018) Side effects of methotrexate therapy for rheumatoid arthritis: a systematic review. Eur J Med Chem 158:502\u2013516","journal-title":"Eur J Med Chem"},{"issue":"1","key":"581_CR127","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/1529-0131(200101)44:1<13::AID-ANR3>3.0.CO;2-6","volume":"44","author":"KJ Warrington","year":"2001","unstructured":"Warrington KJ, Takemura S, Goronzy JJ, Weyand CM (2001) CD4+, CD28\u2212 T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. Arthritis Rheum 44(1):13\u201320","journal-title":"Arthritis Rheum"},{"issue":"suppl_3","key":"581_CR128","doi-asserted-by":"publisher","first-page":"iii17","DOI":"10.1093\/rheumatology\/keh203","volume":"43","author":"A Weaver","year":"2004","unstructured":"Weaver A (2004) The impact of new biologicals in the treatment of rheumatoid arthritis. Rheumatology 43(suppl_3):iii17\u2013iii23","journal-title":"Rheumatology"},{"issue":"4","key":"581_CR129","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1056\/NEJM199901283400401","volume":"340","author":"ME Weinblatt","year":"1999","unstructured":"Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340(4):253\u2013259","journal-title":"N Engl J Med"},{"issue":"1","key":"581_CR130","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.10697","volume":"48","author":"ME Weinblatt","year":"2003","unstructured":"Weinblatt ME, Keystone EC, Furst DE, Moreland LW, Weisman MH, Birbara CA, Teoh LA, Fischkoff SA, Chartash EK (2003) Adalimumab, a fully human anti\u2013tumor necrosis factor \u03b1 monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 48(1):35\u201345","journal-title":"Arthritis Rheum"},{"issue":"16","key":"581_CR131","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1242\/jcs.02532","volume":"118","author":"WA Woodward","year":"2005","unstructured":"Woodward WA, Chen MS, Behbod F, Rosen JM (2005) On mammary stem cells. J Cell Sci 118(16):3585\u20133594","journal-title":"J Cell Sci"},{"issue":"26","key":"581_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399406000135","volume":"8","author":"NM Wulffraat","year":"2006","unstructured":"Wulffraat NM, De Kleer IM, Prakken B (2006) Refractory juvenile idiopathic arthritis: using autologous stem cell transplantation as a treatment strategy. Expert Rev Mol Med 8(26):1\u201311","journal-title":"Expert Rev Mol Med"},{"key":"581_CR133","first-page":"735","volume":"10","author":"Y Xia","year":"2016","unstructured":"Xia Y, Yin R, Fu T, Zhang L, Zhang Q, Guo G, Li L, Gu Z (2016) Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis. Patient Prefer Adherence 10:735","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"581_CR134","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-017-0542-1","volume":"8","author":"L Ye","year":"2017","unstructured":"Ye L, Li L, Wan B, Yang M, Hong J, Gu W, Wang W, Ning G (2017) Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus. Stem Cell Res Ther 8(1):90","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"581_CR135","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.autrev.2017.05.020","volume":"16","author":"M Zeher","year":"2017","unstructured":"Zeher M, Papp G, Nakken B, Szodoray P (2017) Hematopoietic stem cell transplantation in autoimmune disorders: from immune-regulatory processes to clinical implications. Autoimmun Rev 16(8):817\u2013825","journal-title":"Autoimmun Rev"},{"issue":"2","key":"581_CR136","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00198-016-3769-2","volume":"28","author":"CAF Zerbini","year":"2017","unstructured":"Zerbini CAF, Clark P, Mendez-Sanchez L, Pereira RMR, Messina OD, U\u00f1a CR, Adachi JD, Lems WF, Cooper C, Lane NE, I. O. F. C. I. on behalf of the and G. Bone Structure Working (2017) Biologic therapies and bone loss in rheumatoid arthritis. Osteoporos Int 28(2):429\u2013446","journal-title":"Osteoporos Int"},{"issue":"7350","key":"581_CR137","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nature10135","volume":"474","author":"T Zhao","year":"2011","unstructured":"Zhao T, Zhang Z-N, Rong Z, Xu Y (2011) Immunogenicity of induced pluripotent stem cells. Nature 474(7350):212\u2013215","journal-title":"Nature"},{"key":"581_CR138","volume":"2019","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhang X, Xue H, Liu L, Zhu J, Jin T (2019) Autologous mesenchymal stem cell transplantation in multiple sclerosis: a meta-analysis. Stem Cells Int 2019:8536785","journal-title":"Stem Cells Int"}],"container-title":["Advances in Experimental Medicine and Biology","Cell Biology and Translational Medicine, Volume 12"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/5584_2020_581","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T05:39:19Z","timestamp":1668749959000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/5584_2020_581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030719326","9783030719333"],"references-count":138,"URL":"https:\/\/doi.org\/10.1007\/5584_2020_581","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"15 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"<b>Funding:<\/b> We did not receive any funding from any institution.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"<b>Conflict of Interest:<\/b> There is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"<b>Ethical Approval:<\/b> This article does not contain any studies with animals and human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}}]}}